Kevin Hollevoet
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice.
Journal: Pharmaceutics
Published: March 01, 2023
Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model.
Journal: Frontiers in oncology
Published: August 12, 2022
Improved Potency and Safety of DNA-Encoded Antibody Therapeutics Through Plasmid Backbone and Expression Cassette Engineering.
Journal: Human gene therapy
Published: September 06, 2021
Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response.
Journal: Cancer gene therapy
Published: June 22, 2021
Electroporation outperforms in vivo-jetPEI for intratumoral DNA-based reporter gene transfer.
Journal: Scientific reports
Published: May 05, 2020
DNA-Based Delivery of Checkpoint Inhibitors in Muscle and Tumor Enables Long-Term Responses with Distinct Exposure.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 06, 2019
Bridging the Clinical Gap for DNA-Based Antibody Therapy Through Translational Studies in Sheep.
Journal: Human gene therapy
Published: August 07, 2019
Prolonged in vivo expression and anti-tumor response of DNA-based anti-HER2 antibodies.
Journal: Oncotarget
Published: November 30, 2017
State of play and clinical prospects of antibody gene transfer.
Journal: Journal of translational medicine
Published: April 03, 2017
Last Updated: 09/26/2026